These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18024384)

  • 1. Thalidomide induced impotence in male hematology patients: a common but ignored complication?
    Murphy PT; O'Donnell JR
    Haematologica; 2007 Oct; 92(10):1440. PubMed ID: 18024384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.
    Zheng W; Wei G; Ye X; He J; Li L; Wu W; Shi J; Zhang J; Huang W; Xie W; Luo Y; Xue X; Lin M; Huang H; Cai Z
    Leuk Res; 2009 Dec; 33(12):1615-8. PubMed ID: 19773080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide therapy and polyneuropathy in myeloma patients.
    Laaksonen S; Remes K; Koskela K; Voipio-Pulkki LM; Falck B
    Electromyogr Clin Neurophysiol; 2005 Mar; 45(2):75-86. PubMed ID: 15861857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
    Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
    Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis.
    Rus C; Bazzan M; Palumbo A; Bringhen S; Boccadoro M
    J Thromb Haemost; 2004 Nov; 2(11):2063-5. PubMed ID: 15550053
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses.
    Haas PS; Denz U; Ihorst G; Engelhardt M
    Eur J Haematol; 2008 Apr; 80(4):303-9. PubMed ID: 18182082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Desirable and undesirable effects of thalidomide in patients with multiple myeloma].
    Foldyna D; Kamelander J; Krejcí M; Hájek R
    Vnitr Lek; 2003 Nov; 49(11):859-68. PubMed ID: 14689682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 9. Should we screen patients for inherited thrombophilia before starting thalidomide?
    Otrock ZK; Mahfouz RA; El-Hajj II; Harb MI; Sawaya RA
    Am J Clin Oncol; 2006 Feb; 29(1):100-1. PubMed ID: 16462512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide in multiple myeloma: state of art.
    Tosi P; Cavo M
    Haematologica; 2002 Mar; 87(3):233-4. PubMed ID: 11869932
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated thrombocytopenia induced by thalidomide in a patient with multiple myeloma: case report and review of literature.
    Prasad HK; Kaushal V; Mehta P
    Am J Hematol; 2007 Sep; 82(9):855-7. PubMed ID: 17570510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interstitial pneumonia during treatment with thalidomide in a patient with multiple myeloma].
    Iguchi T; Sakoda M; Chen CK; Yokoyama K; Hattori Y; Ikeda Y; Okamoto S
    Rinsho Ketsueki; 2004 Sep; 45(9):1064-6. PubMed ID: 15510838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
    Mateos MV; García-Sanz R; Colado E; Olazábal J; San-Miguel J
    Br J Haematol; 2008 Feb; 140(3):324-6. PubMed ID: 18067473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.
    Dasanu CA; Alexandrescu DT
    Eur J Haematol; 2009 Mar; 82(3):231-4. PubMed ID: 19018868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.
    Corso A; Zappasodi P; Barbarano L; Petrucci MT; Palumbo A; Caravita T; Mangiacavalli S; Cafro AM; Varettoni M; Gay F; Morra E; Lazzarino M
    Leuk Res; 2009 Sep; 33(9):e145-9. PubMed ID: 19375164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
    Hulin C; Facon T; Rodon P; Pegourie B; Benboubker L; Doyen C; Dib M; Guillerm G; Salles B; Eschard JP; Lenain P; Casassus P; Azaïs I; Decaux O; Garderet L; Mathiot C; Fontan J; Lafon I; Virion JM; Moreau P
    J Clin Oncol; 2009 Aug; 27(22):3664-70. PubMed ID: 19451428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?
    Pasa S; Altintas A; Cil T; Ustun C; Bayan K; Danis R; Urakci Z; Tuzun Y; Ayyildiz O
    Int J Infect Dis; 2009 Jan; 13(1):e19-22. PubMed ID: 18621563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide in the treatment of multiple myeloma.
    Kastritis E; Dimopoulos MA
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):681-99. PubMed ID: 18070713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma.
    Zemanova M; Scudla V; Adam Z; Gregora E; Pour L; Minarik J; Pavlicek P; Pika T; Bacovsky J
    Neoplasma; 2008; 55(4):345-9. PubMed ID: 18505347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guideline for the appropriate use of thalidomide in the treatment of multiple myeloma].
    Rinsho Ketsueki; 2005 Jan; 46(1):22-42. PubMed ID: 16724412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.